Engineered as a novel twincretin, it is distinguished by its ability to act as a dual agonist, simultaneously binding to and activating both the Glucose-Dependent Insulinotropic Polypeptide (GIP) and Glucagon-Like Peptide-1 (GLP-1) receptors
CCK producing neurons are known to be important for appetite control
Intranasal administration delivers the peptide efficiently to central nervous system targets, though peripheral effects on neurotrophic factor production may also benefit peripheral nerve health indirectly
medical benefit and how this structure impacts insurance coverage for GLP-1 drugs for diabetes and obesity, including the 20252026 Medicare BALANCE Model, manufacturer price cuts, and employer coverage trends.
Why Food Still Matters on GLP-1 Peptides GLP-1based therapies (including triple agonists like Retatrutide) have shown substantial average weight reductions in clinical trials
Low testosterone causes fatigue, decreased motivation, reduced muscle mass, and poor sleep